Carrozzo I, Maule G, Gentile C, Umbach A, Ciciani M, Guidone D
Mol Ther. 2025; 33(3):970-985.
PMID: 39797401
PMC: 11897810.
DOI: 10.1016/j.ymthe.2025.01.011.
Oh D
Glob Med Genet. 2024; 11(4):319-329.
PMID: 39583120
PMC: 11405120.
DOI: 10.1055/s-0044-1790558.
Stack J, Rayner R, Nouri R, Suarez C, Kim S, Kanke K
Mol Ther Nucleic Acids. 2024; 35(4):102339.
PMID: 39398224
PMC: 11470261.
DOI: 10.1016/j.omtn.2024.102339.
Kulhankova K, Cheng A, Traore S, Auger M, Pelletier M, Hervault M
Nucleic Acids Res. 2024; 52(19):11911-11925.
PMID: 39315713
PMC: 11514481.
DOI: 10.1093/nar/gkae819.
Kavanagh E, Tzeng S, Sharma N, Cutting G, Green J
Biomaterials. 2024; 313:122753.
PMID: 39217793
PMC: 11571037.
DOI: 10.1016/j.biomaterials.2024.122753.
DNA-PKcs Inhibition Improves Sequential Gene Insertion of the Full-Length cDNA in Airway Stem Cells.
Stack J, Rayner R, Nouri R, Suarez C, Kim S, Kanke K
bioRxiv. 2024; .
PMID: 39185207
PMC: 11343149.
DOI: 10.1101/2024.08.12.607571.
High ionic strength vector formulations enhance gene transfer to airway epithelia.
Cooney A, Loza L, Najdawi K, Brommel C, McCray Jr P, Sinn P
Nucleic Acids Res. 2024; 52(16):9369-9383.
PMID: 39077931
PMC: 11381324.
DOI: 10.1093/nar/gkae640.
Cystic fibrosis management in pediatric population-from clinical features to personalized therapy.
Azoicai A, Lupu A, Trandafir L, Alexoae M, Alecsa M, Starcea I
Front Pediatr. 2024; 12:1393193.
PMID: 38798310
PMC: 11116730.
DOI: 10.3389/fped.2024.1393193.
High ionic strength vector formulations enhance gene transfer to airway epithelia.
Cooney A, Loza L, Najdawi K, Brommel C, McCray Jr P, Sinn P
bioRxiv. 2024; .
PMID: 38328187
PMC: 10849541.
DOI: 10.1101/2024.01.22.576687.
Reciprocal mutations of lung-tropic AAV capsids lead to improved transduction properties.
Cooney A, Brommel C, Traore S, Newby G, Liu D, McCray Jr P
Front Genome Ed. 2023; 5:1271813.
PMID: 38077224
PMC: 10702583.
DOI: 10.3389/fgeed.2023.1271813.
Shuttle peptide delivers base editor RNPs to rhesus monkey airway epithelial cells in vivo.
Kulhankova K, Traore S, Cheng X, Benk-Fortin H, Hallee S, Harvey M
Nat Commun. 2023; 14(1):8051.
PMID: 38052872
PMC: 10698009.
DOI: 10.1038/s41467-023-43904-w.
Molecular and functional correction of a deep intronic splicing mutation in by CRISPR-Cas9 gene editing.
Walker A, Graham C, Greenwood M, Woodall M, Maeshima R, OHara-Wright M
Mol Ther Methods Clin Dev. 2023; 31:101140.
PMID: 38027060
PMC: 10661860.
DOI: 10.1016/j.omtm.2023.101140.
Optimization of ionizable lipids for aerosolizable mRNA lipid nanoparticles.
Lewis M, Soto M, Maier E, Wulfe S, Bakheet S, Obregon H
Bioeng Transl Med. 2023; 8(6):e10580.
PMID: 38023707
PMC: 10658486.
DOI: 10.1002/btm2.10580.
Prime editing-mediated correction of the CFTR W1282X mutation in iPSCs and derived airway epithelial cells.
Li C, Liu Z, Anderson J, Liu Z, Tang L, Li Y
PLoS One. 2023; 18(11):e0295009.
PMID: 38019847
PMC: 10686454.
DOI: 10.1371/journal.pone.0295009.
Lung SORT LNPs enable precise homology-directed repair mediated CRISPR/Cas genome correction in cystic fibrosis models.
Wei T, Sun Y, Cheng Q, Chatterjee S, Traylor Z, Johnson L
Nat Commun. 2023; 14(1):7322.
PMID: 37951948
PMC: 10640563.
DOI: 10.1038/s41467-023-42948-2.
Avian influenza A viruses exhibit plasticity in sialylglycoconjugate receptor usage in human lung cells.
Liang C, Huang I, Han J, Sownthirarajan B, Kulhankova K, Murray N
J Virol. 2023; 97(11):e0090623.
PMID: 37843369
PMC: 10688379.
DOI: 10.1128/jvi.00906-23.
Use of adenine base editing and homology-independent targeted integration strategies to correct the cystic fibrosis causing variant, W1282X.
Mention K, Cavusoglu-Doran K, Joynt A, Santos L, Sanz D, Eastman A
Hum Mol Genet. 2023; 32(23):3237-3248.
PMID: 37649273
PMC: 10656707.
DOI: 10.1093/hmg/ddad143.
Protospacer modification improves base editing of a canonical splice site variant and recovery of CFTR function in human airway epithelial cells.
Joynt A, Kavanagh E, Newby G, Mitchell S, Eastman A, Paul K
Mol Ther Nucleic Acids. 2023; 33:335-350.
PMID: 37547293
PMC: 10400809.
DOI: 10.1016/j.omtn.2023.06.020.
The revolution of personalized pharmacotherapies for cystic fibrosis: what does the future hold?.
Oliver K, Carlon M, Pedemonte N, Lopes-Pacheco M
Expert Opin Pharmacother. 2023; 24(14):1545-1565.
PMID: 37379072
PMC: 10528905.
DOI: 10.1080/14656566.2023.2230129.
Genome Editing for Cystic Fibrosis.
Wang G
Cells. 2023; 12(12).
PMID: 37371025
PMC: 10297084.
DOI: 10.3390/cells12121555.